This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,596.34, is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of December 31, 2024 and is a firm fixed-price delivery order. The awardee, AmerisourceBergen Drug Corp, is a for-profit organization registered in the System for Award Management (SAM.gov) and holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.
Generated 3/31/25, 9:30 AM